The Effect of Adding Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Undetectable Pretreatment Epstein-Barr Virus DNA

PURPOSE: To assess the effect of adding neoadjuvant chemotherapy (NACT) to concurrent chemoradiotherapy (CCRT) in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) and undetectable pretreatment Epstein-Barr virus (pEBV) DNA. MATERIALS AND METHODS: We enrolled 639 NPC patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ya-Nan, Yao, Ji-Jin, Wang, Si-Yang, Zhang, Wang-Jian, Zhang, Fan, Zhou, Guan-Qun, Cheng, Zhi-Bin, Mo, Hao-Yuan, Sun, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453864/
https://www.ncbi.nlm.nih.gov/pubmed/28570869
http://dx.doi.org/10.1016/j.tranon.2017.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453864/
https://www.ncbi.nlm.nih.gov/pubmed/28570869
http://dx.doi.org/10.1016/j.tranon.2017.03.007

Ejemplares similares